Drugs / GenSci122
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06772415 | Jan 2025 → Dec 2028 expected | neoplasm | Changchun GeneScience Pharmaceutical Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GenSci122 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06772415 ↗ |
| Action | Inhibit | “KIF18A Inhibitor” NCT06772415 ↗ |
| Route | Oral | “Orally Once Daily” NCT06772415 ↗ |
| Target | KIF18A | “KIF18A Inhibitor” NCT06772415 ↗ |